The First Thai Case of Nondeletional HbH Disease Caused by Compound Heterozygosity for α-Thalassemia-1 Chiang Rai (--CR) Type Deletion with Hb Constant Spring.

IF 1.2 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Hemoglobin Pub Date : 2024-07-01 Epub Date: 2024-08-23 DOI:10.1080/03630269.2024.2388661
Duantida Songdej, Praguywan Kadegasem, Nongnuch Sirachainan, Chedtapak Ruengdit, Manoo Punyamung, Sakorn Pornprasert
{"title":"The First Thai Case of Nondeletional HbH Disease Caused by Compound Heterozygosity for α-Thalassemia-1 Chiang Rai (--<sup>CR</sup>) Type Deletion with Hb Constant Spring.","authors":"Duantida Songdej, Praguywan Kadegasem, Nongnuch Sirachainan, Chedtapak Ruengdit, Manoo Punyamung, Sakorn Pornprasert","doi":"10.1080/03630269.2024.2388661","DOIUrl":null,"url":null,"abstract":"<p><p>Hemoglobin (Hb) H disease presents a wide range of clinical phenotypes, from asymptomatic to severe forms, depending on significant genetic heterogeneity. This is the first report of clinical and hematological features of the nondeletional HbH disease caused by --<sup>CR</sup>/α<sup>CS</sup>α. A baby was born to a father and a mother with --<sup>CR</sup> and α<sup>CS</sup>α carriers, respectively. She had severe symptomatic hypochromic microcytic anemia at 2 months of age with Hb 7.8 g/dL, packed cell volume (PCV) 0.27 L/L, mean corpuscular volume (MCV) 64.3 fL, and mean corpuscular Hb (MCH) 18.3 pg. The Hb analysis using capillary electrophoresis (CE) showed Hb Bart's, HbH, and Hb CS peaks at 17.1%, 2.2%, and 1.6%, respectively. A better understanding of a patient's clinical and hematological features with --<sup>CR</sup>/α<sup>CS</sup>α is useful for hemoglobinopathy counseling for the national thalassemia controlling program.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"261-264"},"PeriodicalIF":1.2000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hemoglobin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03630269.2024.2388661","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/23 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hemoglobin (Hb) H disease presents a wide range of clinical phenotypes, from asymptomatic to severe forms, depending on significant genetic heterogeneity. This is the first report of clinical and hematological features of the nondeletional HbH disease caused by --CRCSα. A baby was born to a father and a mother with --CR and αCSα carriers, respectively. She had severe symptomatic hypochromic microcytic anemia at 2 months of age with Hb 7.8 g/dL, packed cell volume (PCV) 0.27 L/L, mean corpuscular volume (MCV) 64.3 fL, and mean corpuscular Hb (MCH) 18.3 pg. The Hb analysis using capillary electrophoresis (CE) showed Hb Bart's, HbH, and Hb CS peaks at 17.1%, 2.2%, and 1.6%, respectively. A better understanding of a patient's clinical and hematological features with --CRCSα is useful for hemoglobinopathy counseling for the national thalassemia controlling program.

泰国首例由α-地中海贫血-1 清莱(--CR)型缺失与 Hb 常春复合杂合子引起的非缺失型 HbH 病。
血红蛋白(Hb)H 病的临床表型多种多样,从无症状到重症,取决于显著的遗传异质性。这是首次报道由--CR/αCSα引起的非缺失性 HbH 病的临床和血液学特征。一名婴儿的父亲和母亲分别是--CR和αCSα携带者。她在2个月大时患有严重的无症状低色素性小细胞性贫血,血红蛋白(Hb)为7.8 g/dL,充盈细胞体积(PCV)为0.27 L/L,平均血球容积(MCV)为64.3 fL,平均血红蛋白(MCH)为18.3 pg。使用毛细管电泳(CE)进行的 Hb 分析显示,Hb Bart's、HbH 和 Hb CS 峰值分别为 17.1%、2.2% 和 1.6%。通过--CR/αCSα更好地了解患者的临床和血液学特征,有助于为全国地中海贫血控制项目提供血红蛋白病咨询。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hemoglobin
Hemoglobin 医学-生化与分子生物学
CiteScore
1.70
自引率
10.00%
发文量
59
审稿时长
3 months
期刊介绍: Hemoglobin is a journal in the English language for the communication of research and information concerning hemoglobin in humans and other species. Hemoglobin publishes articles, reviews, points of view The journal covers topics such as: structure, function, genetics and evolution of hemoglobins biochemical and biophysical properties of hemoglobin molecules characterization of hemoglobin disorders (variants and thalassemias), consequences and treatment of hemoglobin disorders epidemiology and prevention of hemoglobin disorders (neo-natal and adult screening) modulating factors methodology used for diagnosis of hemoglobin disorders
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信